NATA - Nucleic Acid Therapy Accelerator
0 followers
The Nucleic Acid Therapy Accelerator (NATA) is a new national research initiative with a mission to accelerate the development of nucleic acid therapeutics, while firmly anchoring the nucleic acid (NA) therapy industry in the UK for many years to come. The NATA will be at the Harwell Science and I... Read more
Org chart
Nick Lench
Executive Director
Nick Lench
Collapse
Laura Sepp - Lorenzino
Chief Scientific Officer, Intellia Therapeutics (us)
Shalini Andersson
Chief Scientist Of New Therapeutic Modalities And Head Of Oligonucleotide Discovery, Astrazeneca (sweden)
Alison Smith
Vice President, Portfolio And Technology Delivery, GSK
Anne Willis
Professor Of Toxicology And MRC Toxicology Unit Director, University Of Cambridge (uk)
Similar companies
SimilarWeb
58 followers
Biofidelity
1 follower
Kantar
26 followers
Third Bridge
24 followers
John Innes Centre
3 followers
Diligenta - a subsidiary of Tata Consultancy Services
3 followers
EduBridge
12 followers
SourceWhale
1 follower
Dianthus Therapeutics
1 follower
Edelman
25 followers
Syngene International
22 followers
Discover companies